Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacillus velezensis
- Molecular classification
- Other (Bacterium; Gram-positive, aerobic, endospore-forming, member of family Bacillaceae)
01
Overview
Bacillus velezensis is an aerobic, Gram-positive, endospore-forming bacterium within the genus Bacillus. It was defined as a distinct species following phylogenomic reclassification, absorbing several previously independent Bacillus species. Strains of B. velezensis are widely recognized for their production of bioactive compounds (including lipopeptides such as surfactin, iturin, fengycin, and polyketides like bacillaene, difficidin, and macrolactin) which confer broad-spectrum antimicrobial activity against bacterial, fungal, and nematode pathogens of plants. This bacterium promotes plant growth both directly (e.g., phytohormone production, nitrogen fixation) and indirectly (disease suppression), and it can trigger plant immune responses (induced systemic resistance). B. velezensis is used chiefly as a biocontrol agent in agriculture, rather than as a human therapeutic target.
- Other names
- Bacillus amyloliquefaciens subsp. plantarumBacillus methylotrophicusBacillus oryzicola
02
Biological functions
Plant growth promotionSuppression of microbial pathogens (antagonism)Production of secondary metabolites (e.g., antibiotics, polyketides, lipopeptides)Induction of systemic resistance in plants
03
Disease associations
Infection (from the perspective of plant pathogen suppression; not itself a human/animal disease role)Other (biocontrol agent in agriculture)
04
Safety considerations
Not a human pathogen under normal circumstancesGenerally regarded as safe for plants and environmental use in biocontrol, but as with all biocontrol agents, possible risks should be assessed in each application
Beyond the preview
Go deeper on Bacillus velezensis.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bacillus velezensis.